Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press52410.36691/RJA524ArticlesСтатьиResearch ArticleDiagnosis and treatment of complicated forms of atopic dermatitis in childrenДиагностика и лечение осложненных форм атопического дерматита у детейSmirnovaG IСмирноваГ Иgismirnova@yandex.ruI.M. Sechenov First Moscow state Medical UniversityПервый московский государственный медицинский университет им. И.м. Сеченова15042014112NO2 (2014)№2 (2014)596610032020Copyright ©; 2014, Pharmarus Print MediaCopyright ©; 2014, Фармарус Принт Медиа2014Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/524

The article deals with a clinical and diagnostic criteria and character of skin lesions in children with atopic dermatitis and second infection. Various factors are analysed that influence the course of the disease at different infections, the basic principles of therapy of atopic dermatitis with infections are discussed.

Представлены данные о формировании осложненных форм атопического дерматита (АтД). указаны основные факторы, способствующие развитию осложненных форм АтД у детей. Описаны клинические проявления бактериальной, вирусной и грибковой инфекции кожи при АтД у детей, обоснованы основные направления комплексного патогенетического лечения АтД и инфекций кожи. Детально представлена наружная терапия атопических и инфекционных повреждений кожи у детей с использованием средств современной дерматологической косметики.

bacterialfungal and viral skin infections in childrendiagnosistreatmentPimafucorthealing dermatological cosmeticsатопический дерматит у детейбактериальнаявируснаягрибковая инфекция кожидиагностика и принципы леченияпимафукортнаружная терапияаtopic dermatitisSpergel J.M. Epidemiology of atopic dermatitis and atopic march in children. Immunol Allergy Clin. North Am. 2010, v. 30, р. 269-280.Смирнова Г.И. Современная концепция лечения атопического дерматита. М., «Прима-Центр». 2006, 132 с.Eichenfield L.F., Ellis C.N., Mancini A.J. et al. Atopic dermatitis: epidemiology and pathogenesis update. Semin. Cutan. Med. Surg. 2012, v. 31, р. 3-5.Williams H.C. Epidemiology of human atopic dermatitis - seven areas of notable progress and seven areas of notable ignorance. Vet. Dermatol. 2013, v. 24, р. 3-9.Leung D.Y New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol. Int. 2013, v. 62, р. 151-161.Смирнова Г.И. Новое в патогенезе и лечении атопического дерматита у детей. Рос. педиатр. журн. 2013, № 6, с. 53-57.Kubo A., Nagao K., Amagai M. Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J. Clin. Invest. 2012, v. 122, р. 440-447.McAleer M.A., Irvine A.D. The multifunctional role of filaggrin in allergic skin disease. J. Allergy Clin. Immunol. 2013, v. 131, р. 280-291.Kendall A.C., Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity. Prog. Lipid Res. 2013, v. 52, р. 141-164.Grice E.A., Segre J.A. The skin microbiome. Nat. Rev. Microbiol. 2011, v. 9, р. 244-253.Na S.Y., Roh J.Y., Kim J.M. еt al. Analysis of Colonization and Genotyping of the Exotoxins of Staphylococcus aureus in Patients with Atopic Dermatitis. Ann. Dermatol. 2012, v. 24, р. 413-419.Petry V., Bessa G.R., Poziomczyck C.S. et al. Bacterial skin colonization and infections in patients with atopic dermatitis. An. Bras. Dermatol. 2012, v. 87, р. 729-734.Смирнова Г.И. Современные технологии диагностики и лечения тяжелых форм аллергодерматозов у детей. М., «Альба Плюс». 2006, 156 с.Macleod A.S., Hemmers S., Garijo O. et al. Dendritic epidermal T-cells regulate skin antimicrobial barrier function. J. Clin. Invest. 2013, v. 123, р. 4364-4374.Park H.Y., Kim C.R., Huh I.S. et al. Staphylococcus aureus Colonization in Acute and Chronic Skin Lesions of Patients with Atopic Dermatitis. Ann. Dermatol. 2013, v. 25, р. 410-416.Смирнова Г.И. Диагностика и cовременные методы лечения аллергодерматозов у детей. Рос. педиатр. журн. 2002, № 3, с. 40-44.Ott H., Weißmantel S., Kennes L.N. et al. Molecular microarray analysis reveals allergen- and exotoxin-specific IgE repertoires in children with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2014, v. 28, р. 100-107.Zhang E., Tanaka T., Tajima M. et al. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol. Immunol. 2011, v. 55, р. 625-632.Salgado-Pabón W., Case-Cook L.C., Schlievert P.M. Molecular analysis of staphylococcal superantigens. Methods Mol. Biol. 2014, v. 1085, р. 169-185.Zeeuwen P.L., Kleerebezem M., Timmerman H.M. et al. Microbiome and skin diseases. Curr. Opin. Allergy Clin. Immunol. 2013, v. 13, р. 514-520.Spaulding A.R., Salgado-Pabón W., Kohler P.L. et al. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev. 2013, v. 26, р. 422-447.Zuniga R., Nguyen T. Skin conditions: common skin rashes in infants. FP Essent. 2013, № 407, р. 31-41.Dreyfus D.H. Herpesviruses and the microbiome. J. Allergy Clin. Immunol. 2013, v. 132, р. 1278-1286.Wollenberg A. Eczema herpeticum. Chem Immunol Allergy. 2012, v. 96, р. 89-95.Gao P.S., Rafaels N.M., Hand T. et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J. Allergy Clin. Immunol. 2009, v. 124, р. 507-513.Bin L., Kim B.E., Brauweiler A. et al. Staphylococcus aureus α-toxin modulates skin host response to viral infection. J. Allergy Clin. Immunol. 2012, v. 130, р. 683-691.Difonzo E.M., Faggi E., Bassi A. et al. Malassezia skin diseases in humans. G Ital. Dermatol. Venereol. 2013, v. 148, р. 609-619.Gaitanis G., Velegraki A., Mayser P et al. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin. Dermatol. 2013, v. 31, р. 455-463.Park M., Do E., Jung W.H. Lipolytic enzymes involved in the virulence of human pathogenic fungi. Mycobiology. 2013, v. 41, р. 67-72.Seng P., Abat C., Rolain J.M. et al. Identification of rare pathogenic bacteria in a clinical microbiology laboratory: impact of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Clin. Microbiol. 2013, v. 51, р. 2182-2194.Kooken J., Fox K., Fox A. et al. Identification of staphylococcal species based on variations in protein sequences (mass spectrometry) and DNA sequence (sodA microarray). Mol. Cell Probes. 2014, v. 28, р. 41-50.Biswas S., Rolain J.M. Use of MALDI-TOF mass spectrometry for identification of bacteria that are difficult to culture. J. Microbiol Methods. 2013, v. 92, р. 14-24.Haigh J.D., Green I.M., Ball D. et al. Rapid identification of bacteria from bioMérieux BacT/ALERT blood culture bottles by MALDI-TOF MS. Br. J. Biomed Sci. 2013, v. 70, р. 149-155.Cobo F. Application of maldi-tof mass spectrometry in clinical virology: a review. Open Virol. J. 2013, v. 7, р. 84-90.Смирнова Г.И. Эффективное лечение атопического дерматита у детей. Рос. педиатр. журн. 2012, № 5, с. 23-30.Tan A.U., Gonzalez M.E. Management of severe atopic dermatitis in children. J. Drugs Dermatol. 2012, v. 11, р. 1158-1165.Lim H., Song K., Kim R. et al. Nutrient intake and food restriction in children with atopic dermatitis. Clin. Nutr. Res. 2013, v. 2, р. 52-58.Foolad N., Brezinski E.A., Chase E.P. et al. Effect of Nutrient Supplementation on Atopic Dermatitis in Children: A Systematic Review of Probiotics, Prebiotics, Formula, and Fatty Acids. Arch. Dermatol. 2012, v. 17, р. 1-6.Смирнова Г.И. Энтеросорбенты в комплексном лечении атопического дерматита у детей. Рос. педиатр. журн. 2009, № 1, с. 41-44.Balato A., Paoletti I., De Gregorio V. et al. Tacrolimus does not alter the production of several cytokines and antimicrobial peptide in Malassezia furfur-infected-keratinocytes. Mycoses. 2014, v. 57, р. 176-183.Fleischer A.B. Jr, Feldman S.R. Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatricians. Clin. Ther. 1999, v. 21, р. 1725-1731.Greenberg H.L., Shwayder T.A., Bieszk N. et al. Clotrimazole/ betamethasone dipropionate: a review of costs and complications in the treatment of common cutaneous fungal infections. Pediatr Dermatol. 2002, v. 19, р. 78-81.Смирнова Г.И. Эмольянты в наружной терапии атопического дерматита у детей. Рос. педиатр. журн. 2011, № 4, с. 37-42.Boralevi F., Saint Aroman M., Delarue A. et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J. Eur. Acad. Dermatol Venereol. 2013; doi: 10.1111/ jdv.12314.Schäkel K., Döbel T., Bosselmann I. Future treatment options for atopic dermatitis - Small molecules and beyond. J. Dermatol. Sci. 2014, v. 73, р. 91-100.